We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Aerosol Spray Treats Gastrointestinal Bleeds

By HospiMedica International staff writers
Posted on 21 May 2018
A novel device helps control hemorrhage within the upper and lower gastrointestinal (GI) tract, such as those caused by gastric ulcers, cancer, malformed blood vessels, diverticulosis, or inflammatory bowel disease (IBD).

The Cook Medical (Bloomington, IN, USA) Hemospray is a single-use device that delivers hemostatic powder through the channel of an endoscope toward the source of a bleed. More...
The proprietary inorganic powder absorbs water when it comes in contact with blood, forming a gel barrier that acts cohesively and adhesively to create a stable mechanical barrier that covers the bleeding site. The mineral spray can be delivered to a wide area through an endoscope, covering large ulcers, tumors, or diffuse and hard-to-visualize bleeds.

Hemospray is contraindicated in patients at high risk for GI perforations or with a fistula. The spray is also not intended for use in patients with variceal bleeding, such as from the enlarged veins related to alcoholic liver disease. In a review that summarized 19 studies of the Hemospray device, comprising treatment of 234 patients, a combined rate of successful hemostasis of 88.5% within five minutes was demonstrated. Recurrent bleeding occurred within 72 hours in 16.2% of the patients after successful initial hemostasis with Hemospray.

“Current endoscopic hemostasis treatment options can be challenging. Thermal, mechanical, or contact devices can carry a risk of further tissue damage, and require precise placement of the device directly onto the bleeding vessel,” claimed Cook Medical in a press release. “The Hemospray device represents a different approach to treat GI bleeds by helping to achieve hemostasis without the precision or direct visualization required of other current treatments.”

GI bleeding incorporates all forms of bleeding in the GI tract, from the mouth to the rectum; about 2/3 of all GI bleeds are from upper sources and 1/3 from lower sources. Small amounts of bleeding over a long time may cause iron-deficiency anemia resulting in fatigue, chest or abdominal pain, shortness of breath, and pale skin. Massive bleeding can result in vomited blood, shock, and syncope. Blood that is digested may appear black rather than red, resulting in brown vomit or tar colored stool called melena.

Related Links:
Cook Medical


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.